Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Elan Corporation, plc (ADR) (ELN): The Biggest Insider Trade in History

Elan Corporation, plc (ADR) (NYSE:ELN)By now you’ve probably at least heard of SAC Capital, the massive hedge fund founded and run by the eponymous Steven A. Cohen. It was indicted on Thursday for a decade-long insider trading scandal that the Justice Department has described as “substantial, pervasive and on a scale without known precedent in the hedge fund industry.”

The facts of the case — alleged by the government in multiple court filings, guilty pleas, and indictments — are breathtaking. In short, it’s alleged that the fund intentionally hired analysts and portfolio managers with reputations for insider trading, incentivized them to further cultivate inside information for the benefit of their respective portfolios, and obliged them to share the information with Cohen, who then used it to trade in a separate portfolio that he alone controlled. By doing so, SAC Capital is thought to have earned “hundreds of millions of dollars” in illegal profits and avoided losses.

As investors, there’s a lesson we can learn from this. And, no, the lesson isn’t that insider trading is bad. I mean, it is, but hopefully most of us already know that. Instead, as I read through the court filings describing SAC’s insider contacts and the quality of information its traders had access to ahead of earnings announcements and other material events, it made me realize just how asymmetric the knowledge in the market truly is. In other words, any individual investor who thinks he can beat the market by speculating on things like earnings surprises is living in la-la-land.

Of the dozens of trades alleged in the various documents, the one that best demonstrates this is SAC’s bet on the pharmaceutical giant Elan Corporation, plc (ADR) (NYSE:ELN) in anticipation of the latter’s Phase II trial results for a drug to treat Alzheimer’s disease. I’ve mapped out the trade in the chart below.

During the first half of 2008, and based upon the advice of the doctor in charge of announcing the results, an SAC portfolio manager by the name of Matthew Martoma began constructing a massive stake in Elan Corporation, plc (ADR) (NYSE:ELN), eventually topping out at 10.5 million shares. The move began to look particularly prescient when shares rose more than 10% following the June 17th release of the trial’s top-line results.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.